Biohack Blueprint · DoNotAge Intelligence
DoNotAge research and company developments covering trials, grants, collaborations, certifications, product science and material updates, classified by source and evidence type.
DoNotAge’s 21-day SureSleep cohort analysed 51 customers and 1,472 check-ins. Sleep quality and daytime energy improved strongly, but the single-arm study had no placebo, randomization or blinding.
Real world study analysisTeam NUS PROMETHEUS has advanced to the Top 20 XPRIZE Healthspan finals. Its peer-reviewed multimodal protocol includes DoNotAge SIRT6Activator supplied by DoNotAge.org.
Clinical research newsICR says DoNotAge contributed US$25,000 to its Unicamp rat-rejuvenation replication programme. The project remains preclinical and has not yet reproduced the reported rejuvenation result.
Research funding newsDoNotAge’s 15-in-1 has joined the Informed Sport programme. Here is what batch-level banned-substance certification establishes—and what it does not.
Quality certification newsDoNotAge Performance is a new daily sachet combining 7 g creatine, 4 g Nitralis and 2 g NAC, currently listed as a pre-order product.
Product launch newsDoNotAge now lists creatine and bioenergetics researcher Professor Sergej M. Ostojic on its Scientific Advisory Board.
Company people newsNCT06230861 is a 40-person randomized double-masked quercetin trial sponsored by UCLan with DoNotAge.org listed as collaborator. It remains recruiting with no posted results.
Registered trial newsDoNotAge Trial 2 found a +8.3 µmol/L between-group NAD+ difference in 19 completers. The full dataset was p=0.09; a pre-specified outlier sensitivity analysis was p<0.01.
Trial analysisDoNotAge Trial 1 reports large 60-day improvements in WHO-5 well-being and FACIT-Fatigue versus placebo in 28 completers. The finished formula was tested, but ethics approval remains listed as “to be...
Trial analysisA source-checked guide to NUS PROMETHEUS: the 20-person, eight-week multimodal study used DoNotAge SIRT6Activator at 2.4 g/day, but it was not a standalone SIRT6Activator efficacy trial.
Clinical research newsBSRA says DoNotAge.org funded 15 of 18 small research grants across 13 UK institutions in 2026. This tracker now lists all 15 recipients and separates funding from research outcomes.
Research funding newsContinue the cluster
Move from news or conference coverage into the underlying research, people and policy pillars.
See the projects and the exact relationship to DoNotAge.
Research trackerTrace speakers and investigators to the relevant project or talk.
Scientist directoryTimestamped shipping, returns, subscriptions, guarantees and testing guidance.
Practical guide